Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Anand Arvindbhai Patel has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201113-03-2013
13-03-2013
Limited Review for Dec 31, 2012
Lincoln Pharmaceuticals Ltd has submitted to BSE a Copy of the Limited Review Report for the period ended December 31, 2012.12-02-2013
Financial Results for Dec 31, 2012
Lincoln Pharmaceuticals Ltd has informed BSE about the Financial Results for the period ended December 31, 2012.12-02-2013
Tinnitus Ear Spray
Lincoln Pharmaceuticals Ltd has informed BSE regarding a Press Release dated January 21, 2013, titled "Tinnitus Ear Spray"22-01-2013
Resignation of Director
Lincoln Pharmaceuticals Ltd has informed BSE that Mr. Mihirbhai V. Patel has resigned as Director of the Company with effect from December 01, 2012.05-12-2012
Limited Review for Sep 30, 2012
Lincoln Pharmaceuticals Ltd has submitted to BSE a Copy of the Limited Review Report for the period ended September 30, 2012.08-11-2012
Financial Results for Sep 30, 2012
Lincoln Pharmaceuticals Ltd has informed BSE about the Financial Results for the period ended September 30, 2012.08-11-2012
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Minaben Y Patel has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201125-10-2012
Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Lincoln Pharmaceuticals Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 199225-10-2012
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Shachi Y Patel has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201125-10-2012